trop
Drugs related to atropine.
- Drugs containing trop: 38
- Approved somewhere: 21
- With a US drug page: 14
- Stem
- trop
- Class
- Drugs related to atropine
Approved and clinical-stage drugs in ChEMBL whose names containing trop, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Benztropine | Approved | CHRM1 | Muscarinic acetylcholine receptor M1 antagonist |
| Choriogonadotropin alfa | Approved | LHCGR | Luteinizing hormone/Choriogonadotropin receptor agonist |
| Corticotropin | Approved | MC2R | Melanocortin receptor 2 agonist |
| Ipratropium | Approved | CHRM3 | Muscarinic acetylcholine receptor M3 antagonist |
| Lonapegsomatropin | Approved | GHR | Growth hormone receptor agonist |
| Nitroprusside | Approved | Soluble guanylate cyclase | Soluble guanylate cyclase activator |
| Somatropin | Approved | GHR | Growth hormone receptor agonist |
| Thyrotropin alfa | Approved | TSHR | Thyroid stimulating hormone receptor agonist |
| Tiotropium | Approved | CHRM3 | Muscarinic acetylcholine receptor M3 antagonist |
| Tropicamide | Approved | CHRM3 | Muscarinic acetylcholine receptor M3 antagonist |
| Cosyntropin | Phase 3 | MC2R | Melanocortin receptor 2 agonist |
| Gonadotropin, chorionic | Phase 3 | LHCGR | Luteinizing hormone/Choriogonadotropin receptor agonist |
| Menotropins | Phase 3 | LHCGR, FSHR | Luteinizing hormone/Choriogonadotropin receptor agonist |
| Urofollitropin | Phase 3 | FSHR | Follicle stimulating hormone receptor agonist |
| Atropine | Approved | CHRM3, CHRM1, CHRM2 | Muscarinic acetylcholine receptor M3 antagonist |
| Corifollitropin alfa | Approved | FSHR | Follicle stimulating hormone receptor agonist |
| Follitropin | Approved | FSHR | Follicle stimulating hormone receptor agonist |
| Follitropin alfa | Approved | FSHR | Follicle stimulating hormone receptor agonist |
| Follitropin beta | Approved | FSHR | Follicle stimulating hormone receptor agonist |
| Follitropin delta | Approved | FSHR | Follicle stimulating hormone receptor agonist |
| Lutropin alfa | Approved | LHCGR | Luteinizing hormone/Choriogonadotropin receptor agonist |
| Methylatropine | Approved | — | — |
| Methylhomatropine | Approved | — | Unknown |
| Oxitropium | Approved | — | — |
| Tropisetron | Approved | Serotonin 3 (5-HT3) receptor | Serotonin 3 (5-HT3) receptor antagonist |
| Albusomatropin | Phase 3 | — | — |
| Cimetropium | Phase 3 | — | — |
| Thyrotropin | Phase 3 | TSHR | Thyroid stimulating hormone receptor agonist |
| Darotropium | Phase 2 | Muscarinic acetylcholine receptor | Muscarinic acetylcholine receptor antagonist |
| Deptropine | Phase 2 | — | — |
| Ethybenztropine | Phase 2 | — | — |
| Redalsomatropin alfa | Phase 2 | — | — |
| Somatropin pegol | Phase 2 | — | — |
| Tropatepine | Phase 2 | — | — |
| Tropifexor | Phase 2 | NR1H4 | Bile acid receptor FXR agonist |
| Altropane | — | — | Diagnostic agent |
| Anisotropine | — | CHRM3, CHRM1 | Muscarinic acetylcholine receptor M3 antagonist |
| Corticotropin zinc hydroxide | — | MC2R | Melanocortin receptor 2 agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO